Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Feb 15, 2016; 8(2): 173-185
Published online Feb 15, 2016. doi: 10.4251/wjgo.v8.i2.173
Published online Feb 15, 2016. doi: 10.4251/wjgo.v8.i2.173
Figure 1 Novel compounds under investigation and their predominant targets.
EGFR: Epidermal growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; PDGFR: Platelet derived growth factor receptor; FGFR: Fibroblast growth factor receptor; PI3K: Phosphatidylinositol-4,5-bisphosphate 3-kinase; mTOR: Mammalian target of rapamycin.
- Citation: Thillai K, Ross P, Sarker D. Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis? World J Gastrointest Oncol 2016; 8(2): 173-185
- URL: https://www.wjgnet.com/1948-5204/full/v8/i2/173.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i2.173